Back

drs. U.V. Bomhof

drs. U.V. Bomhof

Associate Professor

Show full profile

Research Output (82)

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation

van den Dries Carline J, van Doorn Sander, Souverein Patrick, Pajouheshnia Romin, Moons Karel G M, Hoes Arno W, Geersing Geert-Jan, van den Ham Hendrika A 23 Dec 2020, In: TH open : companion journal to thrombosis and haemostasis. 4 , p. e417-e426

Design and rationale of DUTCH-AF:a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation

Chu Gordon, Seelig Jaap, Trinks-Roerdink Emmy M., van Alem Anouk P., Alings Marco, van den Bemt Bart, Boersma Lucas Va, Brouwer Marc A., Cannegieter Suzanne C., Ten Cate Hugo, Kirchhof Charles Jhj, Crijns Harry Jgm, van Dijk Ewoud J., Elvan Arif, van Gelder Isabelle C., de Groot Joris R., den Hartog Frank R., de Jong Jonas Ssg, de Jong Sylvie, Klok Frederikus A., Lenderink Timo, Luermans Justin G., Meeder Joan G., Pisters Ron, Polak Peter, Rienstra Michiel, Smeets Frans, Tahapary Giovanni Jm, Theunissen Luc, Tieleman Robert G., Trines Serge A., van der Voort Pepijn, Geersing Geert Jan, Rutten Frans H., Hemels Martin Ew, Huisman Menno V. 24 Aug 2020, In: BMJ Open. 10 , p. 1-9

Antithrombotic management of patients with atrial fibrillation-Dutch anticoagulant initiatives anno 2020

Chu G, Seelig J, Trinks-Roerdink E M, Geersing G J, Rutten F H, de Groot J R, Huisman M V, Hemels M E W 1 Aug 2020, In: Netherlands Heart Journal. 28 , p. 19-24 6 p.

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care:A randomized controlled trial

Geersing Geert-Jan, Hendriksen Janneke M T, Zuithoff Nicolaas P A, Roes Kit C, Oudega Ruud, Takada Toshihiko, Schutgens Roger E G, Moons Karel G M Jun 2020, In: PLoS Medicine. 17 , p. 1-17

Diagnosing deep vein thrombosis in cancer patients with suspected symptoms:an individual participant data meta-analysis

Takada Toshihiko, van Doorn Sander, Parpia Sameer, de Wit Kerstin, Anderson David R, Stevens Scott M, Woller Scott C, Ten Cate-Hoek Arina J, Elf Johan L, Kraaijenhagen Roderik A, Schutgens Roger E G, Wells Phil S, Kearon Clive, Moons Karel G M, Geersing Geert-Jan 20 May 2020, In: Journal of thrombosis and haemostasis : JTH. 18 , p. 2245-2252 8 p.

Clinical pre-test probability adjusted versus age-adjusted D-dimer interpretation strategy for DVT diagnosis:A diagnostic individual patient data meta-analysis

Parpia Sameer, Takach Lapner Sarah, Schutgens Roger, Elf Johan, Geersing Geert Jan, Kearon Clive 1 Mar 2020, In: Journal of Thrombosis and Haemostasis. 18 , p. 669-675 7 p.

Integrated management of atrial fibrillation in primary care:results of the ALL-IN cluster randomized trial

van den Dries Carline J, van Doorn Sander, Rutten Frans H, Oudega Ruud, van de Leur Sjef J C M, Elvan Arif, Oude Grave Lisa, Bilo Henk J G, Moons Karel G M, Hoes Arno W, Geersing Geert-Jan 29 Feb 2020, In: European heart journal. 41 , p. 2836-2844 9 p.

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation:rationale and design of the FRAIL-AF randomised controlled trial

Joosten Linda P T, van Doorn Sander, Hoes Arno W, Nierman Melchior C, Wiersma Nynke M, Koek Huiberdina L, Hemels Martin E W, Huisman Menno V, Roes Kit C, van den Bor Rutger M, Buding Wim F, Rutten Frans H, Geersing Geert-Jan 29 Dec 2019, In: BMJ Open. 9

Ontwikkelingen in prevalentie van atriumfibrilleren en antitrombotica voorschriften

Joosten Linda, van Eerde E.J.B., Rutten Frans H, Geersing Geert Jan 6 Dec 2019, p. 123 136 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not